FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and drug label updates.

According to the FDA, Apple’s Sleep Apnea Notification Feature is not intended to diagnose, treat, or aid in the management of sleep apnea.

Scans were taken starting three weeks before conception, through nine months of pregnancy and then two years postpartum. The study documented a widespread decrease in the volume of gray matter that ...

The latest in health tech? Apple Watch’s FDA-approved sleep apnea detection feature. Approved for Apple Watch Series 9, ...

What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...

“These are scams,” said Kenny Biddle, the chief investigator for the Center of Inquiry, an organization devoted to defending ...

The S&P 500 ended 0.3% lower on Wednesday, Sept. 18, 2024, as the Federal Reserve announced its first interest-rate cut since ...

Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...

The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive ...

said this is believed to be the first ever FDA clearance to treat moderate to severe obstructive sleep apnea and snoring in children. The 510(k) clearance allows medical devices to enter the U.S.

Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing ...